MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$124,385K
Cash and cash
equivalents
$12,667K
Prepaid expenses and
other current assets
$4,856K
Accounts receivable
$2,013K
Total current assets
$143,921K
Operating lease
right-of-use asset
$3,396K
Restricted cash
$1,527K
Property and equipment,
net
$1,304K
Goodwill
$949K
Intangible assets, net
$438K
Other assets
$31K
Total assets
$151,566K
Total liabilities and
stockholders' equity...
$151,566K
Total stockholders'
equity (deficit)
$99,008K
Total liabilities
$52,558K
Accumulated deficit
-$711,949K
Additional paid-in capital
$810,844K
Total current
liabilities
$46,615K
Other long-term
liabilities
$4,353K
Deferred revenue, net of
current portion
$1,590K
Accumulated other
comprehensive income
$111K
Common stock, 0.00001
par value...
$2K
Deferred revenue,
current portion
$26,877K
Accrued liabilities
$14,197K
Operating lease
liabilities - short term
$4,240K
Accounts payable
$1,301K
Back
Back
Balance Sheet
source: myfinsight.com
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)